Figure 3.
Plk4 over-expression leads to loss of hair and its pigmentation. (a) Plk4OE/Plk4OE; p53KO/p53KO mouse exhibiting typical hair loss phenotype. (b) Plk4OE/Plk4OE; p53KO/p53KO mice showing varying degrees of greying hair. (c) Q-RT-PCR analysis of Plk4 and tyrosinase transcripts in extracts of total back skin from mice of indicated genotypes and treatment indicating mean ± s.e. for three independent biological samples and three replicates/sample (+DOX indicates doxycycline treatment). (d) Fontana-Masson staining of cryosections of P2 back skin from mice of indicated genotypes. +DOX indicates treatment with doxycycline. (e) Fontana-Masson staining of P20 back skin cryosections from mice of indicated genotypes and treated with doxycycline where indicated (+DOX). (f) Anagen hair follicle in wild-type back skin immunostained to reveal melanocyte markers KIT (red in merge; white, monochrome), MITF (green) and DCT (blue in merge; white in monochrome). DNA is represented in white. Differentiated melanocytes identified by triple KIT+MITF+DCT+ staining. (g) P2 back skin from Plk4OE/Plk4OE mice without or with Plk4 over-expression (+DOX) showing anagen hair follicle immunostained to reveal melanocyte markers KIT (red in merge; white in monochrome), MITF (green) and DCT (blue in merge; white in monochrome). DNA is white in merge. Note reduction in differentiated melanocytes identified by triple KIT+MITF+DCT+-positive immunostaining. (h) P2 back skin from Plk4OE/Plk4OE; p53KO/p53KO mice without or with Plk4 over-expression (+DOX) showing hair follicles immunostained for melanocyte markers KIT (red in merge; white in monochrome), MITF (green) and DCT (blue in merge; white in monochrome). DNA is white in merge. Differentiated melanocytes (KIT+MITF+DCT+) are reduced in Plk4OE/Plk4OE; p53KO/p53KO (+DOX) mice. (i) Mean numbers ± s.d. of differentiated melanocytes (KIT+MITF+DCT+) per bulb in indicated genotypes and treatments. Significance determined by Student's t-test. *p < 0.05, **p < 0.01 and ***p < 0.005.